Zobrazeno 1 - 10
of 80
pro vyhledávání: '"James W Mitchell"'
Autor:
Kristl Vonck, Arnaud Biraben, Magdalena Bosak, Poul Jørgen Jennum, Vasilios K Kimiskidis, Petr Marusic, James W. Mitchell, Lara N. Ferreira, Martina Ondrušová, Adrian Pana, Ulf Persson, Tim J. vonOertzen, Simona Lattanzi
Publikováno v:
Brain and Behavior, Vol 13, Iss 12, Pp n/a-n/a (2023)
Abstract Background The use of patient‐reported outcomes (PRO) in clinical practice is gaining increasing attention. This study aimed to provide a critical assessment of the current state‐of‐the‐art and beliefs about the use of PRO in the man
Externí odkaz:
https://doaj.org/article/1e892be3a18d4e54961deac7714daec6
Autor:
James W. Mitchell, Adam Noble, Gus Baker, Rachel Batchelor, Francesco Brigo, Jakob Christensen, Jacqueline French, Antonio Gil-Nagel, Alla Guekht, Nathalie Jette, Reetta Kälviäinen, John Paul Leach, Melissa Maguire, Terence O’Brien, Felix Rosenow, Philippe Ryvlin, Phil Tittensor, Manjari Tripathi, Eugen Trinka, Samuel Wiebe, Paula R. Williamson, Tony Marson
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-8 (2022)
Abstract Background A Core Outcome Set (COS) is a standardised list of outcomes that should be reported as a minimum in all clinical trials. In epilepsy, the choice of outcomes varies widely among existing studies, particularly in clinical trials. Th
Externí odkaz:
https://doaj.org/article/ea6743552dd24e56831464c47d62202f
Autor:
Anna Kearney, Elizabeth Gargon, James W. Mitchell, Stephen Callaghan, Farheen Yameen, Paula R. Williamson, Susanna Dodd
Publikováno v:
Journal of Clinical Epidemiology. 158:34-43
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
A 39-year-old lady with relapsing myelin oligodendrocyte glycoprotein antibody (MOG-IgG) associated disease developed coryzal symptoms, malaise, sweating, and postural dizziness. Six days later she presented with painful progressive right visual loss
Externí odkaz:
https://doaj.org/article/efbbaa12adb840058608c440243e23b6
Perspectives of Three African American Chemists: Reflections on Careers, Experiences, and the Future
Publikováno v:
Analytical Chemistry. 94:9952-9959
Three African American analytical chemists, whose primary research careers have focused in the respective sectors of academia, government, and industry, have come together to provide personal perspectives on parameters that have impacted their career
Autor:
Charlotte Morris, James W. Mitchell, Hannah Moorey, Helen-Cara Younan, George Tadros, Alice M. Turner
Publikováno v:
ERJ Open Research, Vol 5, Iss 2 (2019)
There is increasing evidence demonstrating an association between chronic obstructive pulmonary disease (COPD) and cognitive impairment. We present a narrative review of published studies on the subject and a cross-sectional study investigating domai
Externí odkaz:
https://doaj.org/article/ded090bd748e4d29b9ae6a3fb24c66cc
Autor:
James W. Mitchell, Adam Noble, Gus Baker, Rachel Batchelor, Francesco Brigo, Jakob Christensen, Jacqueline French, Antonio Gil-Nagel, Alla Guekht, Nathalie Jette, Reetta Kälviäinen, John Paul Leach, Melissa Maguire, Terence O’Brien, Felix Rosenow, Philippe Ryvlin, Phil Tittensor, Manjari Tripathi, Eugen Trinka, Samuel Wiebe, Paula R. Williamson, Tony Marson
Publikováno v:
Mitchell, J W, Noble, A, Baker, G, Batchelor, R, Brigo, F, Christensen, J, French, J, Gil-Nagel, A, Guekht, A, Jette, N, Kälviäinen, R, Leach, J P, Maguire, M, O’Brien, T, Rosenow, F, Ryvlin, P, Tittensor, P, Tripathi, M, Trinka, E, Wiebe, S, Williamson, P R & Marson, T 2022, ' Protocol for the development of an international Core Outcome Set for treatment trials in adults with epilepsy : the EPilepsy outcome Set for Effectiveness Trials Project (EPSET) ', Trials, vol. 23, no. 1, 943 . https://doi.org/10.1186/s13063-022-06729-4
Background A Core Outcome Set (COS) is a standardised list of outcomes that should be reported as a minimum in all clinical trials. In epilepsy, the choice of outcomes varies widely among existing studies, particularly in clinical trials. This dimini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b1497020491d69ef745649a9a936a72
https://pure.au.dk/portal/da/publications/protocol-for-the-development-of-an-international-core-outcome-set-for-treatment-trials-in-adults-with-epilepsy(19c1d183-ab89-4056-8814-95cbe9e23eb7).html
https://pure.au.dk/portal/da/publications/protocol-for-the-development-of-an-international-core-outcome-set-for-treatment-trials-in-adults-with-epilepsy(19c1d183-ab89-4056-8814-95cbe9e23eb7).html
Publikováno v:
The Lancet Neurology. 22:293
Autor:
Anurag K. Singh, Siddhartha Ganguly, Scott Weir, Sunil Abhyankar, Andrew K. Godwin, Marc Morrison, Joseph P. McGuirk, Mark L. Weiss, James W Mitchell, Leyla Shune, Rupal Soder, Buddhadeb Dawn, Neil Dunavin, Meizhang Li, Haitham Abdelhakim
Publikováno v:
Stem Cell Rev Rep
BACKGROUND: Because of their well-described immunosuppressive properties, allogeneic adult human mesenchymal stromal cells (MSC) derived from bone marrow have demonstrated safety and efficacy in steroid refractory acute graft versus host disease (SR
Publikováno v:
Journal of Central Nervous System Disease, Vol 2012, Iss 4, Pp 105-115 (2012)
Externí odkaz:
https://doaj.org/article/9d3bb8d69c9c4ca88f5d93727f01ea9a